Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus
Go back to Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 4.62 +0.13 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.49 | 52 Week High | $44.38 | |||
| Open | $4.50 | 52 Week Low | $24.47 | |||
| Day High | $4.67 | P/E | 231.00 | |||
| Day Low | $4.45 | EPS | $0.02 | |||
| Volume | 622,961 | |||||
